Fate Therapeutics
FATE
FATE
46 hedge funds and large institutions have $28.2M invested in Fate Therapeutics in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
Holders
46
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$571K | |
| 2 | +$450K | |
| 3 | +$396K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$301K |
| 5 |
Goldman Sachs
New York
|
+$265K |
Top Sellers
| 1 | -$4.4M | |
| 2 | -$3.75M | |
| 3 | -$1.59M | |
| 4 |
KCM
Kingdon Capital Management
New York
|
-$609K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$569K |